Yoshikawa Y - Search Results

1

Development of a novel antidiabetic zinc complex with an organoselenium ligand at the lowest dosage in KK-A(y) mice.

Fujimoto S, Yasui H, Yoshikawa Y. Fujimoto S, et al. Among authors: yoshikawa y. J Inorg Biochem. 2013 Apr;121:10-5. doi: 10.1016/j.jinorgbio.2012.12.008. Epub 2012 Dec 23. J Inorg Biochem. 2013. PMID: 23314593

2

Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.

Sasagawa T, Yoshikawa Y, Kawabe K, Sakurai H, Kojima Y. Sasagawa T, et al. Among authors: yoshikawa y. J Inorg Biochem. 2002 Jan 1;88(1):108-12. doi: 10.1016/s0162-0134(01)00342-7. J Inorg Biochem. 2002. PMID: 11750032

3

Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.

Yoshikawa Y, Ueda E, Kawabe K, Miyake H, Takino T, Sakurai H, Kojima Y. Yoshikawa Y, et al. J Biol Inorg Chem. 2002 Jan;7(1-2):68-73. doi: 10.1007/s007750100266. Epub 2001 Jul 11. J Biol Inorg Chem. 2002. PMID: 11862542

4

Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.

Ueda E, Yoshikawa Y, Ishino Y, Sakurai H, Kojima Y. Ueda E, et al. Among authors: yoshikawa y. Chem Pharm Bull (Tokyo). 2002 Mar;50(3):337-40. doi: 10.1248/cpb.50.337. Chem Pharm Bull (Tokyo). 2002. PMID: 11911195 Free article.

5

Anti-diabetes effect of Zn(II)/carnitine complex by oral administration.

Yoshikawa Y, Ueda E, Sakurai H, Kojima Y. Yoshikawa Y, et al. Chem Pharm Bull (Tokyo). 2003 Feb;51(2):230-1. doi: 10.1248/cpb.51.230. Chem Pharm Bull (Tokyo). 2003. PMID: 12576666 Free article.

6

Insulinomimetic zinc(II) complexes with natural products: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus.

Kojima Y, Yoshikawa Y, Ueda E, Ueda R, Yamamoto S, Kumekawa K, Yanagihara N, Sakurai H. Kojima Y, et al. Among authors: yoshikawa y. Chem Pharm Bull (Tokyo). 2003 Aug;51(8):1006-8. doi: 10.1248/cpb.51.1006. Chem Pharm Bull (Tokyo). 2003. PMID: 12913247 Free article.

7

Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.

Kawabe K, Sasagawa T, Yoshikawa Y, Ichimura A, Kumekawa K, Yanagihara N, Takino T, Sakurai H, Kojima Y. Kawabe K, et al. Among authors: yoshikawa y. J Biol Inorg Chem. 2003 Nov;8(8):893-906. doi: 10.1007/s00775-003-0489-9. Epub 2003 Oct 9. J Biol Inorg Chem. 2003. PMID: 14551811

8

Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.

Kojima Y, Yoshikawa Y, Ueda E, Kondo M, Takahashi S, Matsukura T, Sakurai H, Hiroi T, Imaoka S, Funae Y. Kojima Y, et al. Among authors: yoshikawa y. Res Commun Mol Pathol Pharmacol. 2002;112(1-4):91-104. Res Commun Mol Pathol Pharmacol. 2002. PMID: 15080500

9

A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.

Adachi Y, Yoshida J, Kodera Y, Kato A, Yoshikawa Y, Kojima Y, Sakurai H. Adachi Y, et al. Among authors: yoshikawa y. J Biol Inorg Chem. 2004 Oct;9(7):885-93. doi: 10.1007/s00775-004-0590-8. Epub 2004 Sep 18. J Biol Inorg Chem. 2004. PMID: 15378407

10

Metallokinetic study of zinc in the blood of normal rats given insulinomimetic zinc(II) complexes and improvement of diabetes mellitus in type 2 diabetic GK rats by their oral administration.

Fugono J, Fujimoto K, Yasui H, Kawabe K, Yoshikawa Y, Kojima Y, Sakurai H. Fugono J, et al. Among authors: yoshikawa y. Drug Metab Pharmacokinet. 2002;17(4):340-7. doi: 10.2133/dmpk.17.340. Drug Metab Pharmacokinet. 2002. PMID: 15618684 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results